EverydayHealthLogo
Dr. Sherry Wren, MD

Dr. Sherry Wren, MD

Palo Alto, CA

33 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Wren, Surgeon in Palo Alto, CA?

    Dr. Sherry Wren, MD is a Surgeon, who primarily practices in Palo Alto, CA with 1 additional practice location. She has been practicing for over 33 years and is board certified. Dr. Wren graduated from Loyola University Chicago Stritch School of Medicine and completed her residency at Univ Of Pittsburgh Med Ctr, General Surgery Yale New Haven Hosp, General Surgery. Dr. Wren is fluent in English and Spanish, and is currently seeing new patients. Dr. Wren’s practice accepts Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Wren’s office at (650) 723-4000.
    CastleConnolyTopDoctors

    Castle Connolly Top Doctor

    Castle Connolly Top Doctors are doctor-nominated and selected by a physician-led research team.

    What are Areas of Expertise for Dr. Wren?

    Dr. Sherry Wren, MD is a highly-rated, board-certified Surgeon known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Wren empowers patients to confidently navigate their health journey, specializing in Gastrointestinal Cancer, Minimally Invasive Surgery, Robotic Surgery, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Wren is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Wren go to medical school and complete their residency?

    • Fellowship: University of Pittsburgh School of Medicine,Pittsburgh, Pa, United States

    • Residency: Univ Of Pittsburgh Med Ctr, General Surgery Yale New Haven Hosp, General Surgery | University of Pittsburgh Medical Center

    • Medical School: Loyola Univ of Chicago Stritch Sch of Med, Maywood Il | Loyola University Chicago Stritch School of Medicine

    Is Dr. Wren board certified as a Surgeon?

    Yes, Dr. Sherry Wren, MD is board certified by the American Board of Surgery , American Board of Surgery since 1995

    What languages does Dr. Wren speak?

    Dr. Wren and their clinical team can communicate with patients in the following languages:

    • English
    • Spanish

    What conditions does a Surgeon like Dr. Wren typically treat?

    As a Surgeon, conditions treated by Dr. Sherry Wren may include:

    Please contact Dr. Wren's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.

    What procedures does a Surgeon like Dr. Wren typically perform?

    As a Surgeon, procedures performed by Dr. Sherry Wren may include:

    Please contact Dr. Wren's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.

    Does Dr. Wren accept my insurance?

    Dr. Wren accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Wren accept in Palo Alto, CA?

    Dr. Wren in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • Aetna

    • Blue Cross Blue Shield

    • Blue Cross Blue Shield of Illinois

    • Blue Cross Blue Shield of Michigan

    • Capital Blue Cross

    • Cigna

    • Elevance Health Inc. (formerly Anthem)

    • Harvard Pilgrim

    • Oscar

    • Oxford Health Plans

    View All Insurances

    Where is Dr. Wren's office located?

    Dr. Sherry Wren's Primary Practice

    300 Pasteur Dr

    Palo Alto, CA 94304

    (650) 723-4000

    Get Directions

    G112 Pavahcs

    3801 Miranda Ave # G112

    Palo Alto, CA 94304

    Get Directions

    What hospitals are Dr. Wren affiliated with?

    CastleConnolyTopDoctors

    Castle Connolly Top Hospital

    This doctor is affiliated with a Castle Connolly Top Hospital.

    Dr. Wren has admitting privileges at the following hospitals:

    Recognitions

    Publications

    • Understanding the reliability of american college of surgeons tiol surgical quality improvement, 2014

    • An estimate of hernia prevalence in Sierra Leone from a tionwide community survey., 2014

    • The evolving application of single-port robotic surgery in general surgery, 2014

    • Traumatic injuries in developing countries, 2013

    • Racial and ethnic differences in lymph node examition after colon cancer resection do not, 2012

    • Long-Term Comparison of Endovascular and Open Repair of Abdomil Aortic Aneurysm, 2012

    • Cost-effectiveness of open versus endovascular repair of abdomil aortic aneurysm in the OVER trial, 2012

    • Innovative leadership of casualty care: comment on Elimiting preventable death on the battlefield., 2011

    • Endoscopic clipping of a post-whipple pancreatic bleed, 2009

    • Metastatic colon adenocarcinoma mimicking herpes zoster, 2007

    • Care within a Veterans Hospital - Earlier detection of colon cancer, 2007

    • Transsal small-caliber esophagogastroduodenoscopy for preoperative evaluation of the high, 2007

    • Short- and long-term outcomes of standardized EMR of nonpolypoid, 2007

    • The use of acellular dermal matrix for contamited abdomil wall defects, 2006

    • Concurrent gastric bypass and repair of anterior abdomil wall hernias, 2006

    • Laparoscopic Roux-en-Y gastric bypass at a Veterans Affairs and high-volume academic facilities, 2005

    • Comparison of training on two laparoscopic simulators, 2005

    • Introducing laparoscopic Roux-en-Y gastric bypass at a Veterans Affairs medical facility, 2004

    • Institutiol commitment to rectal cancer screening results in earlier-stage cancers on diagnosis, 2004

    • Utilization of laparoscopic antireflux surgery at a single Veterans Affairs, 2003

    • A novel technique to treat ruptured umbilical hernias in patients with liver cirrhosis, 2003

    • Effective magement of bleeding during tumor resection with a collagen-based hemostatic agent, 2002

    • Intravascular hemolysis from a Clostridium perfringens liver abscess, 2002

    • Decompressive colonoscopy with intracolonic vancomycin administration, 2001

    • Exterl beam radiotherapy for synchronous rectal and prostatic tumors., 2001

    • Does an infected peripancreatic fluid collection or abscess mandate operation?, 2000

    • Clinical and pathologic overlap in nonsteroidal anti-inflammatory drug, 1999

    • Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras, 1998

    • Color flow sonography in evaluating the resectability of periampullary and pancreatic tumors, 1997

    • Selective magement of hepatic adenomas, 1996

    • A NONLETHAL CONDITIONING APPROACH TO ACHIEVE DURABLE MULTILINEAGE MIXED CHIMERISM AND TOLERANCE, 1995

    • EVIDENCE FOR EARLY TH2 T-CELL PREDOMINCE IN XENOREACTIVITY, 1993

    • CHARACTERIZATION OF THE IMMUNOSUPPRESSIVE EFFECTS OF NITRIC-OXIDE IN GRAFT-VS-HOST DISEASE, 1993

    • CHARACTERIZATION OF MATURATION AND FUNCTION OF TURAL-KILLER-CELLS IN XENOGENEIC, 1993

    • T-CELL MITOGENIC RESPONSES IN FULLY XENOGENEIC CHIMERAS, 1992

    • EVIDENCE FOR THYMIC MATURATION OF BOTH RAT AND MOUSE T-CELLS IN MIXED XENOGENEIC CHIMERAS, 1992

    • CROSS-SPECIES TRANSPLANTATION, 1992

    • CROSS-SPECIES TRANSPLANTATION TOLERANCE, 1992

    • CROSS-SPECIES BONE-MARROW TRANSPLANTATION - EVIDENCE FOR RECOGNITION OF SKIN-SPECIFIC ANTIGENS, 1991

    • KINETICS OF EARLY T-CELL REPOPULATION IN FULLY XENOGENEIC CHIMERAS, 1991

    • CROSS-SPECIES BONE-MARROW TRANSPLANTATION - EVIDENCE FOR TOLERANCE INDUCTION, STEM-CELL ENGRAFTMENT, 1991

    • MIXED CHIMERISM TO INDUCE TOLERANCE FOR SOLID ORGAN-TRANSPLANTATION, 1991

    • SUCCESSFUL TRANSFER OF DONOR, 1991

    • CROSS-SPECIES MIXED CHIMERISM, 1991

    • EFFECT OF SELECTIVE T-CELL DEPLETION OF HOST AND OR DONOR BONE-MARROW ON LYMPHOPOIETIC REPOPULATION, 1986

    • CHARACTERIZATION OF MIXED ALLOGENEIC CHIMERAS - IMMUNOCOMPETENCE, INVITRO REACTIVITY, 1985

    • INVIVO AND INVITRO CHARACTERIZATION OF SPECIFIC HYPOREACTIVITY TO SKIN XENOGRAFTS IN MIXED, 1984

    • Understanding the reliability of american college of surgeons national surgical quality improvement, 2014

    • An estimate of hernia prevalence in Sierra Leone from a nationwide community survey., 2014

    • The evolving application of single-port robotic surgery in general surgery, 2014

    • Traumatic injuries in developing countries, 2013

    • The influence of intern home call on objectively measured perioperative outcomes., 2013

    • Telehealth Follow-up in Lieu of Postoperative Clinic Visit for Ambulatory Surgery, 2013

    • The Role of Unconscious Bias in Surgical Safety and Outcomes, 2012

    • Prevention of VTE in nonorthopedic surgical patients, 2012

    • Racial and ethnic differences in lymph node examination after colon cancer resection do not, 2012

    • Single-Port Robotic Cholecystectomy Results From a First Human Use Clinical Study of the New da, 2011

    • Postoperative Pneumonia-Prevention Program for the Inpatient Surgical Ward, 2010

    • Death After Colectomy It's Later Than We Think, 2009

    • Innovation in Safety, and Safety in Innovation, 2014

    • Long-Term Comparison of Endovascular and Open Repair of Abdominal Aortic Aneurysm, 2012

    • Cost-effectiveness of open versus endovascular repair of abdominal aortic aneurysm in the OVER, 2012

    • Innovative leadership of casualty care, 2011

    • Solitary metastatic clear cell carcinoma to the spleen., 2011

    • Endoscopic clipping of a post-whipple pancreatic bleed, 2009

    • Male Patients Above Age 60 have as Good Outcomes as Male Patients 50-59 Years Old at 1, 2009

    • Metastatic colon adenocarcinoma mimicking herpes zoster, 2007

    • Care within a Veterans Hospital - Earlier detection of colon cancer, 2007

    • Transnasal small-caliber esophagogastroduodenoscopy for preoperative evaluation of the high, 2007

    • Short- and long-term outcomes of standardized EMR of nonpolypoid, 2007

    • The use of acellular dermal matrix for contaminated abdominal wall defects, 2006

    • Concurrent gastric bypass and repair of anterior abdominal wall hernias, 2006

    • Laparoscopic Roux-en-Y gastric bypass at a Veterans Affairs and high-volume academic facilities, 2005

    • Preoperative oral antibiotics in colorectal surgery incre, 2005

    • Comparison of training on two laparoscopic simulators, 2005

    • Introducing laparoscopic Roux-en-Y gastric bypass at a Veterans Affairs medical facility, 2004

    • Institutional commitment to rectal cancer screening results in earlier-stage cancers on diagnosis, 2004

    • Utilization of laparoscopic antireflux surgery at a single Veterans Affairs, 2003

    • A novel technique to treat ruptured umbilical hernias in patients with liver cirrhosis, 2003

    • Positron emission tomography in the initial staging of esophageal cancer, 2002

    • Effective management of bleeding during tumor resection with a collagen-based hemostatic agent, 2002

    • Intravascular hemolysis from a Clostridium perfringens liver abscess, 2002

    • Decompressive colonoscopy with intracolonic vancomycin administration, 2001

    • Results of a screening program for prostate cancer, 2001

    • A novel collagen-based composite offers effective hemostasis for multiple surgical indications, 2001

    • External beam radiotherapy for synchronous rectal and prostatic tumors., 2001

    • Does an infected peripancreatic fluid collection or abscess mandate operation?, 2000

    • Clinical and pathologic overlap in nonsteroidal anti-inflammatory drug, 1999

    • Antiviral cytotoxic activity across a species barrier in mixed xenogeneic chimeras, 1998

    • Is cryosurgical ablation appropriate for treating hepatocellular cancer?, 1997

    • Color flow sonography in evaluating the resectability of periampullary and pancreatic tumors, 1997

    • The role of anticoagulation in pylephlebitis, 1996

    • Selective management of hepatic adenomas, 1996

    • Assessment of resectability of pancreatic head, 1996

    • A NONLETHAL CONDITIONING APPROACH TO ACHIEVE DURABLE MULTILINEAGE MIXED CHIMERISM AND TOLERANCE, 1995

    • INDIVIDUAL ASSESSMENT OF VISUAL, 1995

    • PHENOTYPIC CHARACTERIZATION OF A NOVEL BONE-MARROW, 1994

    • EVIDENCE FOR EARLY TH2 T-CELL PREDOMINANCE IN XENOREACTIVITY, 1993

    • CHARACTERIZATION OF THE IMMUNOSUPPRESSIVE EFFECTS OF NITRIC-OXIDE IN GRAFT-VS-HOST DISEASE, 1993

    • CD4+ T-CELLS, BUT NOT CD8+ T-CELLS, 1993

    • CHARACTERIZATION OF MATURATION AND FUNCTION OF NATURAL-KILLER-CELLS IN XENOGENEIC, 1993

    • XENOREACTIVITY IN MOUSE PLUS RAT-]MOUSE CHIMERAS, 1993

    • SUBLETHAL IRRADIATION - A NONLETHAL METHOD TO ACHIEVE CROSS-SPECIES CHIMERISM (RAT-]MOUSE), 1992

    • PREFERENTIAL DEVELOPMENT OF NKR-P1, 1992

    • THE REQUIREMENT FOR ALLOGENEIC CHIMERISM FOR 2ND TRANSFER OF TOLERANCE FROM MIXED ALLOGENEIC, 1992

    • EVIDENCE THAT INDEFINITE SURVIVAL OF SMALL, 1992

    • LONG-TERM SURVIVAL OF DONOR-SPECIFIC PANCREATIC-ISLET XENOGRAFTS IN FULLY XENOGENEIC CHIMERAS, 1992

    • T-CELL MITOGENIC RESPONSES IN FULLY XENOGENEIC CHIMERAS, 1992

    • EVIDENCE FOR THYMIC MATURATION OF BOTH RAT AND MOUSE T-CELLS IN MIXED XENOGENEIC CHIMERAS, 1992

    • MIXED XENOGENEIC CHIMERAS (RAT PLUS MOUSE TO MOUSE) - EVIDENCE OF RAT STEM-CELL ENGRAFTMENT, 1992

    • CROSS-SPECIES TRANSPLANTATION, 1992

    • CROSS-SPECIES TRANSPLANTATION TOLERANCE, 1992

    • CROSS-SPECIES BONE-MARROW TRANSPLANTATION - EVIDENCE FOR RECOGNITION OF SKIN-SPECIFIC ANTIGENS, 1991

    • KINETICS OF EARLY T-CELL REPOPULATION IN FULLY XENOGENEIC CHIMERAS, 1991

    • CROSS-SPECIES BONE-MARROW TRANSPLANTATION - EVIDENCE FOR TOLERANCE INDUCTION, STEM-CELL ENGRAFTMENT, 1991

    • MIXED ALLOGENEIC RECONSTITUTION, 1991

    • MIXED CHIMERISM TO INDUCE TOLERANCE FOR SOLID ORGAN-TRANSPLANTATION, 1991

    • SUCCESSFUL TRANSFER OF DONOR, 1991

    • CROSS-SPECIES MIXED CHIMERISM, 1991

    • EFFECT OF SELECTIVE T, 1986

    • EFFECT OF SELECTIVE T-CELL DEPLETION OF HOST AND OR DONOR BONE-MARROW ON LYMPHOPOIETIC REPOPULATION, 1986

    • CHARACTERIZATION OF MIXED ALLOGENEIC CHIMERAS - IMMUNOCOMPETENCE, INVITRO REACTIVITY, 1985

    • INVIVO AND INVITRO CHARACTERIZATION OF SPECIFIC HYPOREACTIVITY TO SKIN XENOGRAFTS IN MIXED, 1984

    • INHIBITION OF THE GRAFT-VERSUS-HOST RESPONSE BY BCGCW-INDUCED SUPPRESSOR CELLS OR PROSTAGLANDIN-E1, 1983

    What is Dr. Wren's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Wren's National Provider Identifier (NPI) number is 1760402416.

    What common questions do patients ask about Dr. Wren?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Wren

    What is Dr. Sherry Wren's specialty?

    What does a Surgeon do?

    General surgeons are experts in diagnosing and managing surgical conditions which includes preoperative, operative, and postoperative care, as well as addressing complications. Their expertise include the areas such as the alimentary tract, breast, abdomen, skin and soft tissue, endocrine system, head and neck, pediatric surgery, surgical critical care, surgical oncology, trauma, burns, and vascular surgery. General surgeons increasingly utilize minimally invasive and endoscopic techniques to provide proper care. In addition to this, many general surgeons have expertise in transplantation, plastic, and cardiothoracic surgery.

    Is Dr. Sherry Wren affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Wren is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see a Surgeon?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see a Surgeon. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Dr. Sherry Wren accepting new patients in Palo Alto, CA?

    Yes, Dr. Sherry Wren is accepting new patients at this time.

    Does Dr. Sherry Wren offer online booking?

    Please contact Dr. Wren's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Dr. Sherry Wren?

    Please contact Dr. Wren's office at (650) 723-4000 to schedule an appointment.

    Where is Dr. Wren's office located?

    Dr. Wren's office is located in Palo Alto, CA.

    Which board certifications does Dr. Sherry Wren have?

    Dr. Sherry Wren is certified by the American Board of Surgery.